|Full name||Peter Mansell|
Pharmaceuticals (prescription and non-prescription), dietary supplements, functional foods, health issues, cinema, jazz
|Editorial work||News writing, Features writing, Editing, Sub-editing|
|Media outlets regularly worked for||
Global Insight, PharmaTimes, FT OTC Business News, Scrip, PJB Reports, EuraLEX, Nutraceuticals International, WSMI Update, OTC bulletin, Pharma Marketletter, In-Pharmatechnologist.com, DrugResearcher.com.
|PR writing||Contact me for more information|
|Last updated||01-02-2018 10:15|
Peter Mansell is a freelance writer and journalist with more than 25 years’ experience in
the pharmaceutical, health and functional food sectors.
Following six years at Scrip, he edited OTC Business News for Financial Times
newsletters and Nutraceuticals International for Marketletter Publications. He has also
been deputy editor of OTC bulletin and associate editor of Generics bulletin.
Peter is the author of management reports and executive briefings on generic drugs, cancer therapies, prescription-to-OTC switching, counterfeit medicines, patent erosion, borderline medicinal product and health claims for foods, drug pricing and reimbursement, clinical trials, pharmaceutical marketing, market access, medical science liaisons, real-world data and drug value.
As a freelancer, he has worked for clients including GlaxoSmithKline, AstraZeneca, Medicom Excel,
Hill & Knowlton, GCI, Ogilvy, Munro & Forster, WebMD, the World Self-Medication Industry, the
Proprietary Association of Great Britain, IMS, Informa, Global Insight, PharmaTimes, eyeforpharma,
Generics bulletin, Scrip Magazine, ERA News, Pharma Marketletter, In-PharmaTechnolgist.com,
Securing Pharma, Pharmaphorum, FirstWord, Research Partnership and Tribeca Knowledge.